Literature DB >> 9263004

TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture.

P Y Dietrich1, P R Walker, V Schnuriger, P Saas, G Perrin, M Guillard, C Gaudin, A Caignard.   

Abstract

The in vitro stimulation of T lymphocytes is frequently used as a technique to expand specific cells present at low precursor frequency in vivo. However, cells analysed after such procedures may no longer reflect those originally present in vivo because of the variable efficiency of outgrowth of different T cell subpopulations. To systematically assess this and to complement functional assays, we have analysed the TCR repertoire using a new high resolution RT-PCR method to determine TCR beta chain CDR3 transcript length. In the ex vivo analysis of tumor infiltrating lymphocytes (TIL) of renal cell carcinoma and glioblastoma patients, we observed and quantified oligoclonally expanded populations of T cells that were very susceptible to repertoire modification upon subsequent in vitro culture with autologous tumor cells. This in vitro repertoire skewing occurred preferentially with TIL rather than peripheral blood lymphocytes and we noted that tumor cells rather than normal cells of the same tissue type were the most potent inducers of the effect. It was striking that this selection was sometimes negative: certain prominent T cell populations that were highly represented in vivo disappeared after in vitro re-stimulation. This suggests that the presentation of tumor associated antigens during culture may eliminate rather than enrich for in vivo primed T cells. It is clear that in vitro functional tests cannot adequately describe all T cells with tumor specificity. Approaches that allow the assessment of potentially antigen-reactive T cell populations ex vivo are thus an important advance in the global appraisal of anti-tumor T cell immune responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9263004     DOI: 10.1093/intimm/9.8.1073

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.

Authors:  W Herr; E Ranieri; A Gambotto; L S Kierstead; A A Amoscato; L Gesualdo; W J Storkus
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  Improving T cell responses to modified peptides in tumor vaccines.

Authors:  Jonathan D Buhrman; Jill E Slansky
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

3.  Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.

Authors:  Xin Huang; Andrew C Wilber; Lei Bao; Dong Tuong; Jakub Tolar; Paul J Orchard; Bruce L Levine; Carl H June; R Scott McIvor; Bruce R Blazar; Xianzheng Zhou
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

4.  Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR.

Authors:  Daniel J Munson; Colt A Egelston; Kami E Chiotti; Zuly E Parra; Tullia C Bruno; Brandon L Moore; Taizo A Nakano; Diana L Simons; Grecia Jimenez; John H Yim; Dmitri V Rozanov; Michael T Falta; Andrew P Fontenot; Paul R Reynolds; Sonia M Leach; Virginia F Borges; John W Kappler; Paul T Spellman; Peter P Lee; Jill E Slansky
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-15       Impact factor: 11.205

5.  TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.

Authors:  Kimberly R Jordan; Jonathan D Buhrman; Jonathan Sprague; Brandon L Moore; Dexiang Gao; John W Kappler; Jill E Slansky
Journal:  Cancer Immunol Immunother       Date:  2012-02-21       Impact factor: 6.968

6.  Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma.

Authors:  Qiong J Wang; Ken-Ichi Hanada; Paul F Robbins; Yong F Li; James C Yang
Journal:  Cancer Res       Date:  2012-10-15       Impact factor: 12.701

7.  T cell receptor sequencing in autoimmunity.

Authors:  Angela M Mitchell; Aaron W Michels
Journal:  J Life Sci (Westlake Village)       Date:  2020-12

8.  MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy.

Authors:  Georg Dössinger; Mario Bunse; Jeannette Bet; Julia Albrecht; Paulina J Paszkiewicz; Bianca Weißbrich; Isabell Schiedewitz; Lynette Henkel; Matthias Schiemann; Michael Neuenhahn; Wolfgang Uckert; Dirk H Busch
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

9.  Next Generation Sequencing-Based Identification of T-Cell Receptors for Immunotherapy Against Hepatocellular Carcinoma.

Authors:  Yipeng Ma; Jiayu Ou; Tong Lin; Lei Chen; Junhui Chen; Mingjun Wang
Journal:  Hepatol Commun       Date:  2021-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.